Zydus Lifesciences Limited — Updates, 25-04-2025: Press Release

Zydus Lifesciences Limited has signed a purchase agreement to acquire a majority stake in Amplitude Surgical SA, targeting 75.4% at €6.25 per share. This acquisition will boost Zydus’s ownership to a total of 85.6% after completing a previous agreement with two minority shareholders. The deal is expected to close by Q3 2025, subject to typical closing conditions, including necessary approvals from the French government and a re-investment from Amplitude's CEO.

Once finalized, Zydus plans a mandatory simplified tender offer, potentially resulting in over 90% ownership of Amplitude, which enables a squeeze-out procedure. This strategic move enhances Zydus’s portfolio in the surgical technologies market, positioning it well in a growing sector. Investors should watch closely for developments, as this acquisition may provide significant opportunities for growth and expansion in the orthopaedic market.